[28H-pm] Pharmacotherapies (Cancer)-1

Mon. Mar 28, 2022 1:30 PM - 2:30 PM [Room H] Conference Room 221 (Bldg. 2: 2F)

Chair: Ken-ichi Fujita

+Add all to schedule

1:30 PM - 1:42 PM

[28H-pm01S] Role of PI3K-mTOR pathway in regulation mechanisms of the integrated stress response

○Mizuki Takahashi^1,2, Yu Kato², Kazuhiro Kunimasa¹, Yoshikazu Sugimoto², Akihiro Tomida¹ (1. Division of Genome Research, Cancer Chemotherapy, Japanese Foundation for Cancer Research., 2. Division of Chemotherapy, Faculty of Pharmacy, Keio University.)

1:42 PM - 1:54 PM

[28H-pm02S] Molecular mechanisms of 5-fluorouracil resistance in HCT116 human colorectal cancer cells

○Nana Nishizawa¹, Chinatsu Kurasaka¹, Akira Sato¹ (1. Dept. Biochem., Fac. Pharm. Sci., Tokyo Univ. Sci.)

1:54 PM - 2:06 PM

[28H-pm03] Effect of undernutrition and glutamine on anticancer drug treatment of colorectal cancer

○Yuta Murai^1,2, Takuya Iwasawa^2,3, Tomoaki Ito^1,2, Hisaki Kato¹, Riku Yamamoto¹, Shuhei Ueda¹, Shunsuke Sakuraba¹, Mutsumi Sakurada¹, Tomoyuki Kushida¹, Kenichiro Tanaka¹, Hiroshi Maekawa¹, Koichi Sato¹ (1. Juntendo University Shizuoka Hospital Surgery, 2. Juntendo University Shizuoka Hospital Center for Disaster, 3. Toyo University Grad. Sch. Sci. Eng.)

2:06 PM - 2:18 PM

[28H-pm04S] Effects of various proton pump inhibitors on VEGF expression in cancer cells

○Rie Ando^1,2, Kenta Yagi³, Naoki Okamoto^1,2, Mayu Takaoka¹, Fuka Aizawa², Hirofumi Hamano³, Yuki Izawa-Ishizawa⁴, Mitsuhiro Goda^1,2, Yoshito Zamami^1,5, Keisuke Ishizawa^1,2 (1. Department of Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences., 2. Department of Pharmacy, Tokushima University Hospital, 3. Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 4. Department of Pharmacology, Tokushima University Graduate School of Biomedical Sciences., 5. Department of Pharmacy, Okayama University Hospital)

2:18 PM - 2:30 PM

[28H-pm05S] Basic study about the modification of the immuno-microenvironment in tumor tissue treated with the combination of microbubbles and ultrasound and enhancement of the antitumor effect in adoptive immunotherapy

○Tamotsu Maruyama¹, Lisa Munakata¹, Daiki Omata¹, Fumiko Hagiwara¹, Yuno Suzuki¹, Shohei Koyama^2,3, Yoshiaki Okada⁴, Nobuki Kudo⁵, Ryo Suzuki^1,6 (1. Fac. Pharma-Sci., Teikyo Univ., 2. NCC-EPOC, 3. Grad. Sch. Med., Osaka Univ., 4. Grad. Sch. Pharm-Sci., Osaka Univ., 5. Fac. Inf. Sc. Technol. Hokkaido Univ., 6. ACRO, Teikyo Univ.)

Session information